Immune Design Corp buy melinda
Start price
15.03.17
/
50%
€5.77
Target price
17.03.17
€6.31
Performance (%)
10.16%
End price
17.03.17
€6.36
Summary
This prediction ended on 17.03.17 with a price of €6.36. The BUY prediction by melinda finished with a performance of 10.16%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immune Design Corp | - | - | - | - |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % | 46,26 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % | 72,33 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % | 52,28 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % | 55,10 % |
Comments by melinda for this prediction
In the thread Immune Design Corp diskutieren
Tumoren
CMB305
Krebs - soliden Tumoren
Stopped prediction by melinda for Immune Design Corp
Immune Design Corp
Start price
Target price
Perf. (%)
€4.56
01.11.17
01.11.17
€9.92
19.12.17
19.12.17
-23.27%
19.12.17
19.12.17
